COVID-19 Vaccine: A comprehensive status report
The current COVID-19 pandemic has urged the scientific community internationally to find
answers in terms of therapeutics and vaccines to control SARS-CoV-2. Published …
answers in terms of therapeutics and vaccines to control SARS-CoV-2. Published …
[HTML][HTML] COVID-19 vaccine: critical questions with complicated answers
MF Haidere, ZA Ratan, S Nowroz… - Biomolecules & …, 2021 - ncbi.nlm.nih.gov
COVID-19 has caused extensive human casualties with significant economic impacts
around the globe, and has imposed new challenges on health systems worldwide. Over the …
around the globe, and has imposed new challenges on health systems worldwide. Over the …
COVID-19 vaccine: where are we now and where should we go?
S Soleimanpour, A Yaghoubi - Expert review of vaccines, 2021 - Taylor & Francis
Introduction The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has
currently caused the pandemic with a high progressive speed and has been considered as …
currently caused the pandemic with a high progressive speed and has been considered as …
[HTML][HTML] The COVID-19 vaccines: recent development, challenges and prospects
Y Yan, Y Pang, Z Lyu, R Wang, X Wu, C You, H Zhao… - Vaccines, 2021 - mdpi.com
The highly infectious coronavirus disease 2019 (COVID-19) associated with the pathogenic
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to become a …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to become a …
Review on up-to-date status of candidate vaccines for COVID-19 disease
TM Belete - Infection and drug resistance, 2021 - Taylor & Francis
The global pandemic of COVID-19 caused by SARS-CoV-2 continues to spread and poses
serious threats to public health and economic stability throughout the world. Thus, to protect …
serious threats to public health and economic stability throughout the world. Thus, to protect …
[HTML][HTML] COVID-19 vaccines: where we stand and challenges ahead
G Forni, A Mantovani - Cell Death & Differentiation, 2021 - nature.com
In the eleven months elapsed since the identification of the SARS-CoV-2 virus and its
genome, an exceptional effort by the scientific community has led to the development of over …
genome, an exceptional effort by the scientific community has led to the development of over …
[HTML][HTML] COVID-19 vaccines: current understanding on immunogenicity, safety, and further considerations
Q He, Q Mao, J Zhang, L Bian, F Gao, J Wang… - Frontiers in …, 2021 - frontiersin.org
The world has entered the second wave of the COVID-19 pandemic, and its intensity is
significantly higher than that of the first wave of early 2020. Many countries or regions have …
significantly higher than that of the first wave of early 2020. Many countries or regions have …
[HTML][HTML] A Review of the Progress and Challenges of Developing a Vaccine for COVID-19
A novel coronavirus, which has been designated as severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), was first detected in December 2019 in Wuhan China and …
coronavirus 2 (SARS-CoV-2), was first detected in December 2019 in Wuhan China and …
[HTML][HTML] From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development
The global pandemic of COVID-19 caused by SARS-CoV-2 (also known as 2019-nCoV and
HCoV-19) has posed serious threats to public health and economic stability worldwide, thus …
HCoV-19) has posed serious threats to public health and economic stability worldwide, thus …
[HTML][HTML] A COVID-19 vaccine: big strides come with big challenges
J Mellet, MS Pepper - Vaccines, 2021 - mdpi.com
As of 8 January 2021, there were 86,749,940 confirmed coronavirus disease 2019 (COVID-
19) cases and 1,890,342 COVID-19-related deaths worldwide, as reported by the World …
19) cases and 1,890,342 COVID-19-related deaths worldwide, as reported by the World …